Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Vasantrai Ratilal Mehta, Jatin Vasantrai Mehta, Hemal V Mehta HUF, Mrs. Devangi Hemal Mehta, Sachin V Mehta HUF and Mrs. Namrata Sachin Mehta

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases